Myogenin Sarcoma IHC Test | Lahalak Platform
The most accurate test for diagnosing rhabdomyosarcoma in children and adults, providing definitive results that aid in rapid planning for intensive and effective treatment.
Scientific name: Myogenin Immunohistochemistry Test
Immunohistochemical assay for myogenin (myogenic differentiation 1) aims to detect this key early nuclear transcription factor for skeletal muscle differentiation. Myogenin is a highly specific and sensitive marker of skeletal muscle differentiation and is currently the gold standard for confirming the histological diagnosis of rhabdomyosarcoma (RM...
Included Services
- Detailed analysis to detect nuclear expression of the transcription factor Myogenin in tissue samples
- Consult a pathologist specializing in pediatric or soft tissue tumors to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is a tissue sample (biopsy).
- The biopsy specimen should be immediately preserved in 10% formalin, avoiding excessive fixation.
- This analysis is mandatory when rhabdomyosarcoma or any small round blue cell tumor is suspected.
- It is usually requested as part of a comprehensive diagnostic package for small round cell tumors, which also includes MyoD1, Desmin, CD99, NKX2.2, and neurological markers.